Unity Biotechnology Inc

NASDAQ:UBX   4:00:00 PM EDT
2.56
-0.03 (-1.16%)
5:02:07 PM EDT: $2.56 0.00 (0.00%)
Earnings Announcements

UNITY Biotechnology Reports Q3 2022 Results

Published: 11/08/2022 22:55 GMT
Unity Biotechnology Inc (UBX) - Unity Biotechnology, Inc. Reports Third Quarter 2022 Financial Results and Business Updates.
Unity Biotechnology Inc - Qtrly Net Loss per Share $1.36.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.01

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.11

More details on our Analysts Page.